Rizk; Nabil
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rizk; Nabil.The latest application filed is for "extended release methazolamide formulation".
- Rizk; Nabil - Montville NJ
- Rizk; Nabil - Mamaroneck NY
| Patent | Date |
|---|---|
| Extended Release Methazolamide Formulation App 20220160684 - Rizk; Nabil | 2022-05-26 |
| Extended release methazolamide formulation Grant 11,103,485 - Rizk August 31, 2 | 2021-08-31 |
| Extended Release Methazolamide Formulation App 20200253938 - Kind Code | 2020-08-13 |
| Extended release methazolamide formulation Grant 10,493,063 - Rizk De | 2019-12-03 |
| Extended Release Methazolamide Formulation App 20190076408 - Rizk; Nabil | 2019-03-14 |
| Extended release methazolamide formulation Grant 9,980,946 - Rizk May 29, 2 | 2018-05-29 |
| Handheld Apparatus To Determine The Viability Of A Biological Tissue App 20110224518 - Tindi; Jaafar ; et al. | 2011-09-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 